- Title
- Integrated Transcriptomic and Metabolomic Mapping Reveals the Mechanism of Action of Ceftazidime/Avibactam against Pan-Drug-Resistant Klebsiella pneumoniae
- Creator
- Hussein, Maytham; Allobawi, Rafah; Li, Jian; Velkov, Tony; Zhao, Jinxin; Yu, Heidi; Neville, Stephanie L.; Wilksch, Jonathan; Wong, Labell J. M.; Baker, Mark; McDevitt, Christopher A.; Rao, Gauri G.
- Relation
- ACS Infectious Diseases Vol. 9, Issue 12, p. 2409-2422
- Publisher Link
- http://dx.doi.org/10.1021/acsinfecdis.3c00264
- Publisher
- American Chemical Society (ACS)
- Resource Type
- journal article
- Date
- 2023
- Description
- Here, we employed an integrated metabolomics and transcriptomics approach to investigate the molecular mechanism(s) of action of ceftazidime/avibactam against a pan-drug-resistant K. pneumoniae clinical isolate from a patient with urinary tract infection. Ceftazidime/avibactam induced time-dependent perturbations in the metabolome and transcriptome of the bacterium, mainly at 6 h, with minimal effects at 1 and 3 h. Metabolomics analysis revealed a notable reduction in essential lipids involved in outer membrane glycerolipid biogenesis. This disruption effect extended to peptidoglycan and lipopolysaccharide biosynthetic pathways, including lipid A and O-antigen assembly. Importantly, ceftazidime/avibactam not only affected the final steps of peptidoglycan biosynthesis in the periplasm, a common mechanism of ceftazidime action, but also influenced the synthesis of lipid-linked intermediates and early stages of cytoplasmic peptidoglycan synthesis. Furthermore, ceftazidime/avibactam substantially inhibited central carbon metabolism (e.g., the pentose phosphate pathway and tricarboxylic acid cycle). Consistently, the dysregulation of genes governing these metabolic pathways aligned with the metabolomics findings. Certain metabolomics and transcriptomics signatures associated with ceftazidime resistance were also perturbed. Consistent with the primary target of antibiotic activity, biochemical assays also confirmed the direct impact of ceftazidime/avibactam on peptidoglycan production. This study explored the intricate interactions of ceftazidime and avibactam within bacterial cells, including their impact on cell envelope biogenesis and central carbon metabolism. Our findings revealed the complexities of how ceftazidime/avibactam operates, such as hindering peptidoglycan formation in different cellular compartments. In summary, this study confirms the existing hypotheses about the antibacterial and resistance mechanisms of ceftazidime/avibactam while uncovering novel insights, including its impact on lipopolysaccharide formation.
- Subject
- ceftazidime-avibactam; K. pneumoniae; antimicrobial resistance; metabolomics; transcriptomics
- Identifier
- http://hdl.handle.net/1959.13/1496557
- Identifier
- uon:54174
- Identifier
- ISSN:2373-8227
- Language
- eng
- Reviewed
- Hits: 912
- Visitors: 911
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|